🔎 Trials Near Me

Pradžia › Aterosklerozė › Indianas

Aterosklerozė klinikiniai tyrimai Indianas

8 tyrimai dėl Aterosklerozė ieško dalyvių vietose Indianas.

Miestai Indianas

Oficialus tyrimo tekstas (anglų kalba)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07783802

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

  • Asha Clinical Research-Munster,Llc, Hammond
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • IU Health Bloomington, Bloomington
  • Indiana University Health Methodist Hospital, Indianapolis
  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Cardiovascular Research of Northwest Indiana LLC, Munster
  • Velocity Clinical Research - Valparaiso, Valparaiso
Renkami dalyviai3 fazė
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • NANI Research, Fort Wayne
  • Nephrology Physician's LLC, Mishawaka
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Evansville
  • Research Site, Evansville
  • Research Site, Indianapolis
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-24 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

  • American Health Network Research Dept, Muncie
  • American Health Network Research Dept, Muncie
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06813911

Pharmacogenomic Informed Statin Prescribing

  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Renkami dalyviai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-04-13 · NCT06568601

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.